ESSA Pharma Inc.·4

Nov 24, 11:11 AM ET

Wood David S. 4

4 · ESSA Pharma Inc. · Filed Nov 24, 2023

Insider Transaction Report

Form 4
Period: 2023-10-24
Wood David S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-24+3,7503,750 total
    Exercise: $3.91Exp: 2033-10-24Common Shares (3,750 underlying)
Footnotes (1)
  • [F1]25% of the options vest after 12 months from the date of grant. 75% vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4